5 must-know leaders in medicine, science and tech

Dovie Salais

Now more than ever, it is undeniable how integral science and research have become to public health. Nationwide, doctors, scientists and experts are working around the clock to find the most up-to-date and reliable information to prevent and stop the spread of Covid-19.

Here are five must-know women who are shattering ceilings, making groundbreaking discoveries, and spreading public awareness during the global pandemic.

Joy Buolamwini

Joy Buolamwini, founder of Algorithmic Justice League, speaks in New York on March 27, 2019.Bess Adler / Bloomberg via Getty Images

Joy Buolamwini is the founder of the Algorithmic Justice League (AJL), a computer scientist and an expert in artificial intelligence bias. Four years ago, when Buolamwini was a graduate student at MIT’s Media Lab, she began looking into the racial and gender disparities in commercially-available facial recognition technologies. Her research culminated in two groundbreaking, peer-reviewed studies, published in 2018 and 2019, that revealed

Read More

Mothers Medicine CBD Oil Reviews

Dovie Salais

New York, NY – ( NewMediaWire ) – October 10, 2020 –  With such a busy schedules, it becomes difficult to ensure that the consumer is able to take care of their health. People spend a lot of money by visiting the doctor but are unable to get the desired outcomes. Therefore, Mothers Medicine CBD is an all-rounder product that will take care of the health of the consumer. Go To Get Your Order Today

What makes Mothers Medicine CBD different from others?

This is a dietary supplement that will enable its consumers in ensuring that they are having a healthy routine. Mothers Medicine CBD is a natural product that will enable both men and women in making sure that they do not require to consume any other medicines. It will improve the overall functioning of the body and will help in becoming healthy. Mothers Medicine CBD will enter

Read More

How patent law and medicine regulations could affect New Zealand’s access to a COVID-19 vaccine

Dovie Salais

New Zealand has allocated an undisclosed sum, in the order of hundreds of millions of dollars, to access COVID-19 vaccines when they become available.

The funding is on top of a NZ$37 million vaccine strategy, but the government has not released specifics because of commercial sensitivities that “could prevent the best possible deal for New Zealanders”.

Apart from the intricacies of global efforts to develop, test and distribute a vaccine, there are also domestic legal issues the government might need to consider, particularly in patent law and the regulatory review of medicines.

Legislative changes to future-proof the law could avoid delays and lower access costs.

Patent law and access

Some fear pharmaceutical companies could patent a COVID-19 vaccine and hold the world hostage, demanding monopoly prices.

But to get a patent the invention has to be novel and non-obvious. There is possibly enough public information about vaccines currently under investigation

Read More

SPORTS MEDICINE: Vitamin D more vital than ever | John Doherty

Dovie Salais

The best opportunity for preventive care, according to Wojtys, occurs in the teenage years, decades before diagnosis. “Peak bone mass is dependent on 5 main factors: sex, race, hormones, nutrition and physical activity,” he wrote. “Sex and race are nonmodifiable, while nutrition, physical activity and hormones are.

“While all the first 20 years of life are important in bone development, approximately 40% to 60% of adult bone mass is achieved during adolescence. Interestingly, 25% of peak bone mass is acquired during the two-year span around peak height velocity: 12.5 years of age for girls and 14 years of age for boys. Nearly all (90%) peak bone mass will have accrued by the age of 18 years, often determining our fracture risk for the rest of our lives.”

Dietary calcium is key for developing strong bones.

Wojtys advises teenagers get 1,300 mg per day for optimal growth. “Keeping in mind that

Read More

Jane Seymour watched Dr. Quinn, Medicine Woman with her grandchildren

Dovie Salais

Jane Seymour posing for a picture

© Bang Showbiz
Jane Seymour

Jane Seymour watched ‘Dr. Quinn, Medicine Woman’ with her grandchildren amid the coronavirus lockdown.

The 69-year-old actress plays Dr. Michaela Quinn-Sully on the TV drama series, and she revisited the show – which ran on CBS between 1993 and 1998 – during the health crisis.

Jane shared: “The parents don’t usually let them watch TV.

“Every once in a while, they get to either watch ‘War With Grandpa’ or ‘Dr. Quinn’ or something.”

The actress joked that the show feels “very appropriate right now”.

Speaking to Us Weekly magazine, Jane explained: “I couldn’t believe that episode two is about an epidemic. We made that how many years ago? Way ahead of our time.”

The film and TV star has also killed time amid the health crisis by having fun in her garden.

She said: “We have an organic garden at the backside of our property.

Read More

Rediscovering Traditional Arabic and Islamic Medicine at Zulal Wellness Resort

Dovie Salais

As the use of traditional medicine continues to gain momentum around the world, Zulal Wellness Resort is set to bring Traditional Arabic and Islamic Medicine (TAIM) to the forefront of the wellness industry in Qatar, the region and the world.

Traditional Arabic and Islamic Medicine contains an abundant source of ancient healing wisdom and guidelines for healthy living, much of which has been forgotten in the present era. Similar to all traditional medical systems, TAIM encompasses a holistic approach to wellness based on the traditional principles that were derived from ancient physicians and focuses mainly on lifestyle wellness practices. Many innovative concepts and practices from Traditional Arabic and Islamic Medicine have influenced and inspired the development of modern medicine.

As the largest wellness destination in the country, the first full-immersion wellness resort in the Middle East and the first centre for Traditional Arabic and Islamic Medicine in the world, Zulal

Read More

Alfardan Group and Northwestern Medicine open new healthcare facility at Lusail City

Dovie Salais

Alfardan Group in partnership with Northwestern Medicine, has ventured into the medical sector in the country with the opening of Alfardan Medical with Northwestern Medicine (AMNM), a patient-centric, ambulatory care centre at Lusail City.

The details of the new centre were announced at a webinar on Sunday, attended by officials of Alfardan Group as well as Northwestern Medicine.

Omar Hussain Alfardan, president and CEO of Alfardan Group; Dr Jessica Adam, chief medical officer of AMNM; Dr Daniel Derman from Northwestern Medicine and other officials took part in the webinar.

AMNM is the result of an international collaboration between Alfardan Group and US-based Northwestern Medicine. At AMNM’s state-of-the-art treatment facilities, service excellence, combined with advanced patient-centric care, is provided by a multinational medical team with top US medical talent making up a large proportion of the centre’s staff.

Omar Alfardan said: “The co-operation between us and Northwestern Medicine is built on

Read More

How Carrier and Amazon are trying to improve refrigerated shipping

Dovie Salais
  • Shipping refrigerated foods, medicines, and vaccines is a precarious business.
  • “Fundamentally, if one thing goes wrong there’s a domino effect,” Amazon Web Services general manager Sarah Cooper said.
  • $28 billion refrigeration company Carrier is working with Amazon Web Services to develop a new digital platform to help connect the fragmented set of companies responsible for shipping refrigerated goods and alert them when weather or traffic conditions may cause cargo delays.
  • Are you an Amazon Web Services employee? Contact this reporter via the encrypted messaging app Signal (+1-425-344-8242) or email (astewart@businessinsider.com).
  • Sign up here to receive updates on all things Innovation Inc. 

Shipping refrigerated food and medicine requires precise coordination between many different companies to keep the goods at just the right temperature as they pass through various trucks, ships, and containers, even in extreme weather conditions.

This refrigerated supply chain can be precarious, even as it’s used to

Read More

Philogen Announces Publication of Malignant Brain Tumor Study Results in Science Translational Medicine | News

Dovie Salais

SIENA, Italy, Oct. 8, 2020 /PRNewswire/ — Philogen S.p.A., a clinical-stage biotechnology company focused on antibody-based therapeutics, is pleased to announce the publication of a peer-reviewed scientific article in Science Translational Medicine. The article is entitled: “Immunocytokines are a promising immunotherapeutic approach against glioblastoma” (T. Weiss, E. Puca, M. Silginer, T. Hemmerle, S. Pazahr, A. Bink, M. Weller, D. Neri, P. Roth, Immunocytokines are a promising immunotherapeutic approach against glioblastoma. Sci. Transl. Med. 12, eabb2311 (2020)) and can be accessed here.

The findings of the study show how Philogen’s proprietary antibody-cytokine fusions, called immunocytokines, demonstrated striking single-agent anti-cancer activity in immunocompetent preclinical models bearing orthotopic glioblastoma. Moreover, the treatment induced long-term tumor eradications in a proportion of the treated animals. These findings were of particular relevance as preclinical models with glioblastoma cannot be cured by any current standard of care. 

The article also discusses initial clinical results of the

Read More

Progenity to Present Precision Medicine Abstracts at American College of Gastroenterology (ACG) …

Dovie Salais

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

October 9, 2020 GMT

SAN DIEGO, Oct. 09, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, is pleased to announce that two abstracts related to Progenity’s ingestible technologies for the diagnosis and treatment of gastrointestinal disorders have been accepted for presentation at American College of Gastroenterology (ACG) virtual annual meeting set to take place October 23-28, 2020. Progenity will be presenting one oral presentation and one poster presentation.

The accepted abstract titles and study findings will be a part of the event’s on-demand sessions and virtual e-poster hall, which are embargoed until October 26

Read More